Currently, the division has five active research laboratories. These laboratories are nationally recognized for their contributions to the understanding of new treatments of hepatitis C, role of quasispecies in hepatitis C, interaction of HIV and hepatitis C viruses, viral host immunology, mechanisms of bilirubin transport and physiological roles of bilirubin, nutritional consequences of and treatment of liver diseases, inflammatory bowel diseases and C difficile infection.
These laboratories are available to medical residents interested in an elective experience in a basic research laboratory.
Opportunities for those interested in greater research focus during GI fellowship also exist using the T32 and F32 mechanisms offered by the NIH.
We have an extensive and well-developed clinical research program. In addition to GI fellows, participation in the programs is also available to house staff. Some of these include treatment of chronic viral hepatitis, reflux esophagitis, upper GI bleeding, inflammatory bowel disease, irritable bowel syndrome and peptic ulcer disease. We anticipate even further expansion of our clinical trials program.
Current Clinical Trials
Government-funded clinical trials at the UC Academic Health Center can be found at the Clinical Trials Webpage. Please note this is not an all-inclusive list.